# Exploring the Association between Diagnostic and Therapeutic Radiation and the Incidence of Vestibular Schwannoma: A Case–Control Study

## TL;DR

This study investigates whether radiation exposure is linked to vestibular schwannoma, finding no significant association after excluding recent treatments.

## Contribution

The study provides new insights into the potential role of radiation in vestibular schwannoma development using a case–control design.

## Key findings

- Therapeutic radiation showed a significant association with VS, but this was not significant after excluding recent treatments.
- Diagnostic imaging (X-ray, CT, MR) was not significantly associated with VS risk.
- The study highlights the need for larger studies to confirm these findings and explore dose–response effects.

## Abstract

Ionizing radiation is a known risk factor for various neoplasms, yet its link with vestibular schwannoma (VS) remains unclear. Given that VSs are benign tumors of the eighth cranial nerve, elucidating potential associations with radiation is of clinical interest. This study investigated the association between diagnostic and therapeutic head and neck radiation exposure and VS.

In a case–control design, we enrolled 137 patients with VS, matched by age and sex with 659 controls. Data were obtained through structured interviews, capturing sociodemographic factors and history of therapeutic head and neck radiation, as well as imaging examinations (X-ray, computed tomography [CT], and magnetic resonance [MR], excluding the last 2 years). Weighted distributions were used to account for up to six controls per case. We used conditional logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs).

The mean age of participants was 53 ± 14.6 years, with 50.4% females. An initial significant association was observed between therapeutic radiation and VS (adjusted OR = 4.94, 95% CI: 2.49–7.98). However, excluding participants who recently underwent radiation therapy attenuated this association (adjusted OR = 2.32, 95% CI: 0.59–9.07;
p
 = 0.22). No significant associations were found for diagnostic imaging (ORs of 1.04 [0.86–1.25], 1.18 [0.73–1.92], and 1.19 [0.57–2.49] for X-ray, CT, and MR, respectively).

Our findings do not support a significant relationship between either therapeutic or diagnostic head and neck radiation exposure and the risk of VS, once recent treatments are excluded. Additional large-scale studies are necessary to confirm these observations and to examine potential dose–response effects.